Compare WYETH LTD with - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

WYETH LTD vs ALKEM LABORATORIES - Comparison Results

WYETH LTD     Change

Wyeth Limited is the 51% subsidiary of Wyeth, US and is the sixth largest company among multinationals with revenues of Rs 2.9 bn in FY07. The company derives its revenues from pharmaceutical and OTC segments with focus on various therapeutic areas s... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    WYETH LTD ALKEM LABORATORIES WYETH LTD/
ALKEM LABORATORIES
 
P/E (TTM) x 27.7 - - View Chart
P/BV x 5.3 6.7 79.8% View Chart
Dividend Yield % 1.3 0.6 197.0%  

Financials

 WYETH LTD   ALKEM LABORATORIES
EQUITY SHARE DATA
    WYETH LTD
Mar-13
ALKEM LABORATORIES
Mar-16
WYETH LTD/
ALKEM LABORATORIES
5-Yr Chart
Click to enlarge
High Rs1,0441,589 65.7%   
Low Rs8181,232 66.4%   
Sales per share (Unadj.) Rs298.6417.5 71.5%  
Earnings per share (Unadj.) Rs57.256.3 101.7%  
Cash flow per share (Unadj.) Rs58.464.7 90.3%  
Dividends per share (Unadj.) Rs17.0012.70 133.9%  
Dividend yield (eoy) %1.80.9 202.8%  
Book value per share (Unadj.) Rs249.5292.9 85.2%  
Shares outstanding (eoy) m22.72119.57 19.0%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x3.13.4 92.3%   
Avg P/E ratio x16.325.1 64.9%  
P/CF ratio (eoy) x15.921.8 73.1%  
Price / Book Value ratio x3.74.8 77.5%  
Dividend payout %29.722.6 131.6%   
Avg Mkt Cap Rs m21,157168,653 12.5%   
No. of employees `0000.5NA-   
Total wages/salary Rs m4009,171 4.4%   
Avg. sales/employee Rs Th13,787.4NM-  
Avg. wages/employee Rs Th813.0NM-  
Avg. net profit/employee Rs Th2,643.3NM-  
INCOME DATA
Net Sales Rs m6,78349,915 13.6%  
Other income Rs m3531,645 21.4%   
Total revenues Rs m7,13651,561 13.8%   
Gross profit Rs m1,6178,482 19.1%  
Depreciation Rs m271,006 2.6%   
Interest Rs m6671 0.8%   
Profit before tax Rs m1,9388,451 22.9%   
Minority Interest Rs m0-114 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m-50-   
Tax Rs m6321,606 39.4%   
Profit after tax Rs m1,3016,731 19.3%  
Gross profit margin %23.817.0 140.3%  
Effective tax rate %32.619.0 171.7%   
Net profit margin %19.213.5 142.2%  
BALANCE SHEET DATA
Current assets Rs m6,98427,062 25.8%   
Current liabilities Rs m2,05615,324 13.4%   
Net working cap to sales %72.623.5 308.9%  
Current ratio x3.41.8 192.4%  
Inventory Days Days9967 149.3%  
Debtors Days Days2441 58.0%  
Net fixed assets Rs m24412,610 1.9%   
Share capital Rs m227239 95.0%   
"Free" reserves Rs m5,44134,490 15.8%   
Net worth Rs m5,66835,027 16.2%   
Long term debt Rs m251,212 2.1%   
Total assets Rs m7,90154,387 14.5%  
Interest coverage x353.313.6 2,597.6%   
Debt to equity ratio x00 12.8%  
Sales to assets ratio x0.90.9 93.5%   
Return on assets %16.513.6 121.5%  
Return on equity %22.919.2 119.4%  
Return on capital %34.024.9 137.0%  
Exports to sales %0.212.9 1.7%   
Imports to sales %36.33.1 1,177.8%   
Exports (fob) Rs m156,461 0.2%   
Imports (cif) Rs m2,4651,540 160.1%   
Fx inflow Rs m156,563 0.2%   
Fx outflow Rs m2,6773,012 88.9%   
Net fx Rs m-2,6623,552 -75.0%   
CASH FLOW
From Operations Rs m9237,259 12.7%  
From Investments Rs m3171,864 17.0%  
From Financial Activity Rs m-481-9,273 5.2%  
Net Cashflow Rs m759-150 -506.1%  

Share Holding

Indian Promoters % 0.0 66.9 -  
Foreign collaborators % 51.1 0.0 -  
Indian inst/Mut Fund % 11.3 33.1 34.1%  
FIIs % 7.2 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 30.4 0.0 -  
Shareholders   21,978 68,381 32.1%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare WYETH LTD With:   PLETHICO PHARMA  DIVIS LABORATORIES  FULFORD INDIA  NATCO PHARMA  AJANTA PHARMA  

Compare WYETH LTD With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 21 Points Higher; Banking and Oil & Gas Stocks Witness Buying(Closing)

Indian share markets witnessed buying interest during closing hours today and ended their day marginally higher.

Related Views on News

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

Is Hawkins Set to Become Our Next Superhero Stock?(The 5 Minute Wrapup)

Nov 1, 2019

After PI Industries, Hawkins has put up a stellar show so far.

Ditch the Risky Fixed Deposits for Safer 'Bluechip Deposits'(Profit Hunter)

Oct 30, 2019

Most people think stocks are riskier than fixed deposits and bonds. The last quarter century proves otherwise.

Crash Alert! Is There a Big Bubble in Nestle, HUL and Asian Paints?(Profit Hunter)

Nov 7, 2019

Is this the beginning of the end of multibagger gains in quality stocks like Nestle, HUL, and Asian Paints?

What to Buy at Sensex 40,000(The 5 Minute Wrapup)

Nov 4, 2019

Should you invest in high-quality, safe stocks or make some contrarian bets in the smallcap space?

The Top Stocks for 2020 Pass This Most Critical Metric(The 5 Minute Wrapup)

Nov 5, 2019

Charlie Munger's favorite fictional character, Mr Glotz, picks stocks using this metric.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

WYETH LTD SHARE PRICE


Dec 9, 2014 (Close)

TRACK WYETH LTD

  • Track your investment in WYETH LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

WYETH LTD 8-QTR ANALYSIS

COMPARE WYETH LTD WITH

MARKET STATS